Lakeside Advisors, Inc. Abb Vie Inc. Transaction History
Lakeside Advisors, Inc.
- $148 Million
- Q4 2024
A detailed history of Lakeside Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Lakeside Advisors, Inc. holds 16,876 shares of ABBV stock, worth $3.25 Million. This represents 2.02% of its overall portfolio holdings.
Number of Shares
16,876
Previous 17,176
1.75%
Holding current value
$3.25 Million
Previous $3.39 Million
11.59%
% of portfolio
2.02%
Previous 2.17%
Shares
13 transactions
Others Institutions Holding ABBV
# of Institutions
4,064Shares Held
1.28BCall Options Held
17.8MPut Options Held
15.7M-
Vanguard Group Inc Valley Forge, PA173MShares$33.4 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$26.3 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$15.4 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$9.98 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$7.65 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $341B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...